A critical barrier in the treatment of endosomal and lysosomal diseases is the lack of understanding 28 of the in vivo functions of the putative causative genes. We addressed this by investigating a key pair 29 of endocytic adaptor proteins, PH domain containing endocytic trafficking adaptor 1 and 2 30
Introduction 45
Endocytic trafficking is essential for a variety of biological processes, including nutrient 46 uptake, cell signaling, and cellular morphogenesis (Doherty and McMahon, 2009 ). This diversity in 47 cellular functions is reflected in the broad range of pathologies associated with deficiencies in 48 endocytic factors. For example, mutations in endocytic factors dynamin 2 (DNM2) and RAB7 result 49 in Charcot-Marie-Tooth disease, a clinically and genetically heterogeneous group of peripheral 50 neuropathies (Verhoeven et al., 2003; Züchner et al., 2005) . Disruptions in endocytosis have been 51 identified in autosomal recessive hypercholesterolemia (Garuti et al., 2005) and autosomal 52 dominant polycystic kidney disease (Obermüller et al., 2001) . These disparate clinical outcomes 53 resulting from endocytic protein deficiency underscore the importance of investigations in the 54 loss of mannose 6-phosphate-dependent targeting resulted in hypersecretion of multiple lysosomal 85 enzymes (Kudo et al., 2006; Koehne et al., 2016) . Dysregulation of cathepsins in MLII zebrafish 86 models resulted in craniofacial and skeletal deformations, recapitulating the clinical features of 87 MLII patients (Spranger and Wiedemann, 1970 we found that zebrafish pheta1 and pheta2 are required for endocytosis, ciliogenesis, and 104 craniofacial development. The disruption in craniofacial development in the pheta1/2 mutants was 105 associated with a dysregulation in cathepsin K activity, likely due to its mislocalization. The 106 abnormal craniofacial development is exacerbated further in the presence of the R6C variant, 107 suggesting a dominant-negative mode of action in human disease. 108 auditory impairments, and renal tubular or glomerular dysfunction ( Fig. 1A-B and Table 1) . exome sequencing and Sanger sequencing of the patient, unaffected fraternal twin, and unaffected 115 parents identified a heterozygous de novo arginine (R) to cysteine (C) mutation in PHETA1 116 (NM_001177997.2:c.55C>T; p.R6C in the short isoform, p.R19C in the long isoform, 117 NM_001177996.1) only in the patient (Fig. 1C) . The R6 residue in PHETA1 is highly conserved 118 across species (Fig. 1D) (Papadopoulos and Agarwala, 2007) , and the R6C mutation was predicted 119 to be damaging with the use of Polyphen (Probably damaging, HumDiv: 1; HumVar: 0.995), SIFT 120 (Deleterious, Score 0.01), and MutationTaster (Disease causing, Prob:1) (Adzhubei et al., 2010; Sim 121 et al., 2012; Schwarz et al., 2014) . This variant has been reported in ExAC browser with minor allele 122 frequency of 0.000009398 (1/106410). Using patient-derived fibroblasts, we find that the R6C 123 mutation does not affect the mRNA expression of PHETA1 (Fig.1E ) 124
Protein modeling was performed using the I-TASSER, MUSTER, and PHYRE2 servers (Fig. 125 suggesting that zebrafish pheta1 is the most likely ortholog of PHETA1 (Fig. S1A) . The pheta2 locus 143 lacked obvious synteny with either the PHETA1 or PHETA2 loci. Based on overall amino acid sequence 144 similarity, zebrafish Pheta1 is more similar to mammalian PHETA1 and PHETA2 (57.3% and 48.9% 145 similarity, respectively), while Pheta2 is more divergent (44.2% and 39.2% similarity, respectively) ( Fig.  146   S1B) . 147
To determine the functions of pheta1 in vivo, we generated a mutant allele of pheta1 utilizing 148 CRISPR genome engineering (Jao et al., 2013; Auer et al., 2014; Gagnon et al., 2014; Irion et al., 2014; 149 Hisano et al., 2015) . The resulting mutant allele, pheta1 vt2 , contains a thirty-eight base pair (38bp) deletion 150 after the start codon, resulting in frame shift and predicted premature translational termination, suggesting 151 that this is likely a null allele (Fig. 2B ). In addition, in order to test for potentially redundant functions of 152 pheta1 and pheta2, we also generated a pheta2 mutant allele. This mutant allele, pheta2 vt3 , contains an 153 eleven base pair (11bp) deletion in exon 2, also resulting in a frame-shift and predicted premature 154 translational termination, suggesting that this is also a null allele ( Fig. 2B) . 155
Zygotic pheta1 vt2 homozygous mutants (pheta1-/-) were viable and fertile, with no gross 156 abnormalities during development. The same was true for zygotic pheta2 vt3 homozygous mutant animals 157 (pheta2-/-). The presence of both the pheta1 and pheta2 transcripts in the 1-cell stage embryo indicated 158 that this gene is maternally inherited (Fig. S2) , and the maternal transcript might compensate for the loss 159 of zygotic transcripts during the early stages of development. We therefore focused on the maternal-160 zygotic pheta1 and pheta2 mutants (progeny from homozygous mutant mothers), which lacked functional 161 maternal and zygotic transcript during development. We also generated maternal-zygotic pheta1-/-162 ;pheta2-/-double-knockout mutants (referred to as dKO) to test for redundant functions between the two 163 PHETA proteins in the zebrafish. We found that maternal-zygotic pheta1-/-, pheta2-/-, and dKO animals 164 were viable and fertile as well, with no gross abnormalities during development. Therefore, pheta1 and 165 pheta2 were not required for viability and fertility in zebrafish. 166
Loss of pheta1 and pheta2 impaired fluid-phase endocytosis 167
Previous findings in ocrl deficient zebrafish and the UDP patient phenotypes suggested that 168 pheta1/2 might regulate endocytosis in the renal system (Oltrabella et al., 2015) . We examined renal 169 endocytosis in the zebrafish, utilizing an established assay in which fluorescent tracers were 170 injected into the common cardinal vein (CCV), followed by filtration and reabsorption into the renal 171 tubular cells lining the pronephric kidney, commonly referred to as the pronephros (Drummond et 172 al., 1998; Oltrabella et al., 2015) . Endocytic uptake into the renal tubular cells can then be analyzed 173 using fluorescent microscopy. We first tested fluid-phase endocytosis and micropinocytosis, using 174 10 kDa fluorescent dextran as the tracer (Li et al., 2015) . Animals were injected at 3 days post 175 fertilization (dpf) and then categorized into three groups: good endocytic uptake, low uptake, or no 176 uptake (Fig. 3A) . The pheta1 heterozygous (pheta1 +/-) and homozygous (pheta1 -/-) animals showed 177 a trend of reduced tracer uptake, compared to the wild-type (WT) control animals, but the 178 difference did not reach statistical significance. The dKO animals, however, exhibited a significant 179 reduction in tracer uptake compared to WT controls (Fig. 3B) . This suggests that pheta1 and pheta2 180 acted redundantly for fluid-phase endocytosis, such that endocytic deficit was only observed when 181 both proteins were depleted. 182
To verify that the reduction of 10 kDa dextran uptake in the dKO animals was a fluid-phase 183 endocytosis-specific defect, and not due to the disruption of the glomerular filtration barrier, we 184 tested glomerular filtration in the pheta1-/-and dKO animals by injecting 500 kDa dextran. 500 kDa 185 dextran is too large to pass through a normally functioning glomerular filtration barrier, so it is 186 expected to remain in the bloodstream. As shown in Fig. 3C , the 500 kDa dextran was retained in 187 the bloodstream in both the pheta1-/-and dKO animals at 24 hours post-injection (hpi), like that of 188 the WT controls. Together, these results show that pheta1/2 are required specifically for fluid-phase 189 endocytosis in the renal organ. 190
Consistent with the in vitro findings that OCRL and PHETA1/2 physically and functionally 191 interact during endosomal trafficking, we found that reduction of zebrafish ocrl gene function 192 significantly enhanced the fluid-phase endocytosis deficits in dKO animals. To inhibit ocrl function, 193
we injected a previously validated ocrl anti-sense morpholino (MO) at the 1-cell embryonic stage 194 and then later injected the 10kDa dextran (Coon et al., 2012) . Injection of 5 ng/nl ocrl MO in the WT 195 animals resulted in a severe reduction of dextran uptake, as previously described (Oltrabella et al., 196 2015) . Injection of 4 ng/nl ocrl MO in WT animals results in a partial reduction of dextran uptake. 197
The same ocrl MO concentration, however, resulted in a more severe reduction in dextran uptake 198 in dKO animals ( Fig. 3D ). This suggests that ocrl and pheta1/2 functionally interact in zebrafish to 199 enable fluid-phase endocytosis. Interestingly, although ocrl is required for receptor mediated 200 uptake of the receptor-associated protein (RAP) (Anzenberger et al., 2006; Oltrabella et al., 2015) , 201 we found no significant differences among WT, pheta1-/-, and dKO animals in RAP endocytic uptake 202 ( Fig. 3E) . Together, these results indicate that pheta1/2 are only involved in a subset of ocrl's 203 edocytic functions, specifically fluid-phase endocytosis. 204
Loss of pheta1/2 disrupted ciliogenesis in the pronephros 205
Several in vitro studies have described defects in ciliogenesis after OCRL depletion, and it 206 was suggested that OCRL regulates protein trafficking to the cilia in a Rab8/PHETA1-dependent 207 manner (Coon et al., 2012; Luo et al., 2012; Rbaibi et al., 2012) . To determine if depletion of pheta1 208 and/or pheta2 affect ciliogenesis or cilia maintenance in vivo, we analyzed the cilia in the 209 pronephros of 3 dpf larvae. We found that dKO animals had shorter and fewer cilia, similar to the 210 phenotype seen in ocrl-deficient fish ( Fig. 4) (Oltrabella et al., 2015) . Since dKO animals exhibited a 211 similar cilia phenotype like that of the ocrl mutants, this further supports the hypothesis that OCRL 212 and PHETA proteins are involved in the same pathway. 213
We next examined if there was a potential ciliary deficit in other ciliated organs, including 214 the inner ear (macula and crista), the olfactory placode, and the lateral line. We found no disruption 215 of ciliogenesis or cilia maintenance in these tissues analyzed in pheta1-/-and dKO animals ( Fig. S3) . 216 We also examined the outer segments of photoreceptors, which are specialized cilia that originate 217 from the apical-most region of the inner segment. Staining with rod and cone photoreceptor 218 markers did not reveal any differences among WT, pheta1-/-, pheta2-/-, and dKO animals ( Fig. S3) . 219
This suggests that pheta1/2's role in ciliogenesis was restricted to the pronephros. 220 pheta1/2 is not required for oculomotor function 221
The UDP patient was born with multiple visual complications, including deficits with 222 oculomotor function (e.g., congenital exotropia, amblyopia, nystagmus). To test whether a 223 deficiency in PHETA1/2 contributes to oculomotor deficits, we analyzed the optokinetic response 224 (OKR) in the pheta1/2 mutants. OKR is a gaze stabilization response that utilizes the extraocular 225 muscles to stabilize a image on the retina in response to visual motion. It is necessary for 226 maintaining optimal visual acuity and is conserved in all vertebrates (Huang and Neuhauss, 2008) . 227
In zebrafish, OKR develops early and is robust by 3-4 dpf (Easter and Nicola, 1997; Huang and 228 Neuhauss, 2008) . To ensure complete development of OKR, we tested 5-6 dpf larvae. Animals were 229 placed inside a circular arena with projections of moving black and white gratings, and the eye 230 positions were video-recorded ( Fig. S4A) . The grating directions alternated clockwise and counter-231 clockwise at different contrasts at 3-second periodicity. We tested siblings in the progeny of 232 pheta1/2 double heterozygous animals (pheta1+/-;pheta2+/-) and the eye velocity in response to 233 the moving gradients was analyzed. No significant differences in eye velocity were observed among 234 WT, pheta1-/-, pheta2-/-, or dKO siblings. We then investigated the correlation of velocity and angle 235 between the left and right eyes ( Fig. S4B-C) . A reduced correlation would suggest strabismus, in 236 which the eyes do not properly align with each other. No significant differences in angle or velocity 237 correlation were observed among WT, pheta1-/-, pheta2-/-, or dKO siblings. Thus, the deficiency in 238 pheta1/2 did not affect oculomotor function. 239
Loss of pheta1/2 disrupts craniofacial morphogenesis 240
As mentioned previously, PHETA1 and PHETA2 were previously found to be involved in the 241 sorting of lysosomal hydrolases in vitro. Disruption of this pathway in vivo could give rise to 242 craniofacial abnormalities as seen in lysosomal storage disorders such as MLII (Kudo et al., 2006; 243 Koehne et al., 2016) . We investigated craniofacial development in our pheta1/2 mutants by 244 performing morphometric measurements of cartilage structures in 6 dpf larvae stained with Alcian 245 Blue (cartilage) and Alizarin Red (bone). WT, pheta1-/-, pheta2-/-, and dKO animals were analyzed. 246
Representative lower jaw ( Fig. 5A, 6A ) and upper jaw (neurocranium, Fig. 5B ) images of the WT 247 and mutants are shown. We did not observe any loss of craniofacial structures, but the mutants 248 tended to have shorter and narrower jaws. To quantitate this potential difference, we made three 249 primary measurements: a) cranial distance; b) jaw width; c) ceratohyal length ( Fig. 5C-F) . Together, 250 these measurements informed us about the overall length and proportions of the head, as well as 251 the growth of an individual cartilage structure (ceratohyal). Indeed, we found a significant reduction 252 in these three metrics in the pheta2-/-and dKO animals, while the loss of pheta1-/-alone only mildly 253 (though significantly) affected jaw width. A similar trend was seen in other craniofacial 254 measurements ( Fig. S5) . Depletion of both pheta1 and pheta2 had an additive effect, indicating 255 functional redundancy during craniofacial development. 256
Loss of pheta1/2 disrupts chondrocyte maturation 257
The craniofacial morphogenesis defects observed in pheta1/2 mutants suggest an 258 underlying developmental abnormality. To test this, we first examined the morphology of 259 chondrocytes, which assume a more elongated shape when mature (Goldring et al., 2006) . If there 260 is a delay in early chondrocyte maturation, the chondrocytes can persist with more rounded 261 morphology, with a long axis:short axis ratio closer to one. This can be measured in flat-mount 262 preparations of the lower jaw ( Fig. 6A-B) . We examined the chondrocytes in the ceratohyal 263 cartilage and analyzed the ratio of the long axis to the short axis of individual cells. We found a slight 264 but significant reduction in the elongation of chondrocytes in the pheta1-/-, pheta2-/-, and dKO 265 animals, suggesting a delay in chondrocyte maturation ( Fig. 6C) . We then asked if differences in 266 chondrocyte proliferation could account for the reduced length of cartilage structures. Indeed, there 267 was a 20% reduction in the number of cells in the ceratohyal cartilage of dKO animals compared to 268 WT controls ( Fig. 6D) . No significant differences in cell number were observed in the Meckel's 269 cartilage (data not shown). Taken together, the altered chondrocyte morphology and reduced 270 chondrocyte proliferation seen in the ceratohyal cartilage suggest that there was a disruption in 271
proper chondrocyte maturation and differentiation in the pheta1/2 mutants. 272
Next, we examined the expression of various markers that characterize the sequential stages at 4 dpf showed that pheta2-/-and dKO animals exhibited a striking increase compared to WT 280 controls, while the pheta1-/-animals had a modest increase ( Fig. 6E-G) . This is consistent with our 281 morphometric analyses, in which pheta2-/-and dKO animals exhibited a more severe deficit in 282 overall craniofacial development compared to pheta1-/-animals. Due to the apparent increase in 283 protein expression of Col2, we performed quantitative RT-PCR to investigate RNA expression levels 284 of col2a1a (Fig. S6A) . We found no significant increase in col2a1a expression at 4dpf, suggesting 285 that the increased Col2 protein levels may be a result of altered translation or matrix turn over. We 286 also analyzed acana (aggrecan), a later-stage extracellular matrix marker, and found a trend for 287 decreased acana expression in the pheta2-/-and dKO animals at 4 dpf, compared to WT (Fig. S6B) . 288
Lastly, we wanted to determine if there is a sustained upregulation in the sox9a transcription factor 289 at later stages. The Sox9 transcription factor is required for early chondrocyte development, but 290 sustained Sox9 expression can inhibit later stages of maturation. At 4 dpf, in situ hybridization 291 revealed an increase in sox9a expression in portions of the lower jaw (indicated by black 292 arrowheads) in the pheta2-/-and dKO animals ( Fig. 7A) . Together, these molecular profiling 293 findings support the hypothesis that a delay in chondrocyte maturation results in a deficiency in 294 craniofacial morphogenesis. involved in the transport of lysosomal hydrolases from the TGN to the endosomes, we hypothesized 302 that cathepsin K dysregulation caused by a deficiency in pheta1/2 may also cause deficits in 303 craniofacial development. To test this, animals were treated with a cathepsin K -specific inhibitor, 304 odanacatib, at 3 dpf and then collected and immunostained for Col2 at 4 dpf (Gauthier et al., 2008; 305 Flanagan- Steet et al., 2018) . Odanacatib significantly reduced Col2 in the dKO animals at both 25 nM 306 and 50 nM concentrations ( Fig. 7B-C) . Interestingly, there was no reduction in pheta1-/-and 307 pheta2-/-, indicating that pheta1 and pheta2 my be able to compensate for one another in regulating 308 cathepsin K activity ( Fig. S7) . 309
Next, we asked if pheta1/2 affects the level of cathepsin K activity. We utilized a cathepsin-310 specific activity-based probe (ABP), BMV109, to measure cathepsin activity in both WT and 311 pheta1/2 mutants (Verdoes et al., 2013; Flanagan-Steet et al., 2018). The animals were treated at 3 312 dpf, a period when several cathepsin activities typically begin to wane in WT animals (Flanagan-313 Steet et al., 2018) . pheta1/2 deficiency did not significantly impact cathepsin L activity. Cathepsin K 314 activity, however, was more variable in the pheta1/2 mutant animals, with a trend toward increased 315 activity in pheta2-/-animals ( Fig. 7D-F) . Thus, the rescue effects of a cathepsin K inhibitor in dKO 316 animals may reflect another mechanism of dysregulation or a broader imbalance of protease 317 activity. 318 pheta1 R6C exerts a dominant-negative effect on craniofacial development 319
One striking clinical feature identified in the UDP patient is her abnormal craniofacial 320 development. The patient presented with coarse facial features and facial asymmetry. She also had 321 shorter feet and palms, as well as dental abnormalities, including skeletal malocclusion. This could 322 be due to PHETA1 haploinsufficiency or dominant-negative effects of the R6C allele. If pheta1 R6C was 323 non-functional or partly functional, then ectopic expression of Pheta1 R6C in pheta1+/-or pheta1-/-324 backgrounds should have no effect or partially improve craniofacial development. However, if 325 pheta1 R6C was dominant-negative, then ectopic expression of pheta1 R6C should worsen craniofacial 326 development in the same backgrounds. Thus, we generated two zebrafish transgenic lines, one that 327 ubiquitously expressed an EGFP-Pheta1 R6C fusion protein [Tg(R6C)], and another that expressed 328 EGFP fused with WT Pheta1 [Tg(WT)] (Fig. 8A) . Confocal imaging confirmed the broad expression 329 of Tg(R6C) and Tg(WT). (Fig. 8B) . 330
To mimic the genetic background of the UDP patient, which is heterozygous for the R6C 331 allele, we analyzed the effects of Tg(R6C) and Tg(WT) in the pheta1 heterozygous (pheta1 +/-) 332 background. We also analyzed the effects of Tg(R6C) and Tg(WT) in the pheta1 homozygous 333 (pheta1 -/-) background to test whether there could be an effect in the absence of pheta1. We found 334 that, in the partial and complete absence of pheta1, pheta1 R6C exacerbated the jaw width defect ( Fig.  335 8C-D). This suggest that the R6C allele has dominant-negative effects. Transgenic expression of WT 336 Pheta 1 had not significant effects in either pheta1+/-or pheta1-/-backgrounds, indicating that the 337 effect on jaw width was specific to the expression of the R6C variant. There was no effect on cranial 338 distance or ceratohyal length (Fig. S8) . Interestingly, Pheta1 R6C impacted the craniofacial 339 morphometrics that were affected by the loss of both pheta1 and pheta2 (jaw width), but not the 340 morphometrics that were only affected by the loss of pheta2 (cranial distance and ceratohyal 341 length). This suggests that Pheta1 R6C may have a relatively limited capacity to interfere with Pheta2 342 function. 343
Discussion 345
The regulation of endocytic trafficking is essential for the development and function of an 346 organism. In this study, we present the first in vivo investigation of the functions of PHETA proteins, 347 which are membrane adaptor proteins for the Lowe syndrome causative protein, OCRL. Using 348 zebrafish as the experimental system, we found that pheta1 and pheta2 were necessary for renal 349 fluid-phase endocytosis and ciliogenesis. Furthermore, we found that loss of pheta1/2 impaired 350 craniofacial development and altered the composition of the cartilage extracellular matrix. Evidence 351 also indicates that cathepsin K is a contributing factor dysregulated by the deficiency of pheta1/2 352 during craniofacial development. We identified a novel role for pheta1 and pheta2 in craniofacial morphogenesis. Craniofacial 381 development appeared to rely more on pheta2, but depletion of both pheta1 and pheta2 resulted in 382 an additive effect, indicating that pheta1 plays a role as well. In pheta2-/-and dKO animals, we 383 observed features indicative of abnormal chondrocyte maturation, including abnormal chondrocyte 384 morphology, changes in marker gene expression, and altered extracellular matrix composition (i.e., 385 increased Col2). As a first foray into the underlying molecular mechanisms, we found that inhibition 386 of cathepsin K using the specific inhibitor odanacatib significantly reduced Col2 protein levels in the 387 dKO animals. This indicated that aberrant cathepsin K activity contributes to abnormal craniofacial 388 development. Interestingly, we did not see a consistent systemic increase in cathepsin K activity 389 using an in vivo activity probe (BMV109), indicating that the dysregulation of cathepsin K activity 390 may be regional or stem from its mislocalization. Future studies might explore where active 391 cathepsin K resides as development progresses and how Col2 levels are modulated by protease 392 activity in pheta1/2 mutant animals. Our previous findings have shown that TGF-β signaling is 393 enhanced by cathepsin K activity, which may, in turn, mediate the abnormal craniofacial 394 morphogenesis in the absence of pheta1/2. 395
Investigating the pathogenesis of the UDP patient's disease 396
A primary motivation for understanding the in vivo function of PHETA1/2 was the 397 identification of a patient carrying a de novo PHETA1 mutation. While the R6C mutation did not 398 affect interaction with OCRL, it did exert a dominant-negative effect on craniofacial development, 399 even in the absence of endogenous pheta1. Since the R6C mutant can interact with OCRL, it may be 400 able to compete with other OCRL interacting protein such as PHETA2 or APPL1. Alternatively, since 401 PHETA1 and PHETA2 can form homodimers and heterodimers, the R6C mutant may bind to and 402 interfere with the normal functions of PHETA1 and PHETA2. Our hypothesis that the R6C mutation 403 resulted in a deficiency of PHETA1/2 function is supported by the overlapping phenotypes between 404 the patient and our zebrafish mutants, specifically in craniofacial development and renal function 405 (Table 1) . 406 We note that the UDP patient has three other de novo mutations considered less likely to be 407 contributing to disease. One variant in DNAJB5 (DnaJ heat shock protein family (Hsp40) member 408 B5; NM_001135004: p.R419H) has inconsistent predictions with SIFT and Polyphen, and occurs in 409 a moderately conserved amino acid, so it is unlikely that this causes the UDP patient's disease. A 410 second variant, in UPP1 (Uridine phosphorylase 1; NM_003364:p.I117V), is seen in 12 normal 411 individuals and is predicted benign by SIFT and Polyphen, so it is unlikely to be pathogenic. The 412 third variant, is in PHF6 (Plant homeodomain (PHD)-like finger protein 6; NM_001015877.1: 413 p.Leu244del), which has been associated with X-linked Borjeson-Forssman-Lehmann syndrome 414 (BFLS; MIM #301900); one female patient has been reported with a loss of function allele and X-415 inactivation (Turner et al., 2004) . X-inactivation studies in our patient showed a skewed pattern, 416 but an association with PHF6 was unlikely due to a lack of phenotypic overlap with BFLS. 417 Furthermore, the variant identified in our patient, unlike a clear loss of function mutation reported 418 in BFLS, leads to an in-frame deletion with no splicing defect (Fig. S9) . 419
Conclusions 420
In conclusion, we have determined novel in vivo functions of the OCRL adaptor proteins, 421 PHETA1 and PHETA2. Deficiency in pheta1/2 resulted in impaired renal physiology and craniofacial 422 development in zebrafish, resembling the renal and craniofacial phenotypes in a UDP patient 423 carrying a dominant-negative allele of PHETA1. The craniofacial deficits in zebrafish pheta1/2 424 mutants were likely caused by a dysregulation of cathepsin K, which altered the extracellular 425 composition of craniofacial cartilages. This results support the hypothesis that PHETA1 mutation 426 was contributory to disease, but further studies with additional patients will be needed to 427 determine the roles of PHETA1/2 in human disease fully. The pheta1 vt2 allele harbored a 38 base pair deletion (frame shift), resulting in the deletion of a 470
MwoI restriction site, which was used to distinguish between wild-type and pheta1 vt2 alleles. 471
Genomic DNA flanking the deletion was amplified by PCR, followed by MwoI digestion for 2 hours 472 at 60°C (primer sequences: cctcaaacaaactagcggacgtgtcgagta and cgcgacagagcctttacccatgattccata). 473
After MwoI digestion, the cut wild-type bands were 230 and 300 base pairs in length, whereas the 474 mutant band was 531 base pairs (uncut). The pheta2 vt3 allele harbored an 11 base pair deletion, 475 resulting in the deletion of a NlaIII restriction site, which was used to distinguish between wild-type 476 and pheta2 vt3 alleles. Genomic DNA flanking the deletion was amplified by PCR, followed by NlaIII 477 digestion for 2 hours at 37°C (primer sequences: ggacggtcagttctgtttctct and 478 catgtaaacataccttcgtatcgtc). After NlaIII digestion, the cut wild-type bands were 180 and 44 base 479 pairs in length, whereas the mutant band was 213 base pairs (uncut). 480 Tg(ubi:pheta1 WT ) and Tg(ubi:pheta1 R6C ) zebrafish transgenic lines were generated utilizing the 481 Tol2-transgenesis system (Kawakami, 2007) . Coding sequence for EGFP was ligated in frame to the 482 3' end of the coding sequence of either the wild-type (Pheta1 WT ) or the patient-specific (pheta1 R6C ) 483
Pheta1 protein, and placed into the Tol2 vector, preceded by the zebrafish ubiquitin promoter from 484 the (Mosimann et al., 2011) . The Tol2-ubi:pheta1 WT and Tol2-ubi:pheta1 R6C vectors were then 485 injected with Tol2 transposase mRNA into wild-type zebrafish larvae at the 1-cell stage. Potential 486 founders were crossed to wild-type fish at 2-3 months of age and offspring was screened for EGFP-487 positive F1 founders. 488
Whole Mount In Situ Hybridization 489
In situ hybridization was performed using standard protocols described previously (Prober et al., 490 2008; Pan et al., 2012) . Sense and antisense probes were transcribed from linearized plasmid DNA 491 using the MEGAshortscript T7 (Ambion) and mMessage mMachine SP6 (Ambion) transcription kits, 492 respectively. 493
Histochemistry and Immunohistochemistry 494
Alcian blue and Alizarin red staining was performed as previously described (Javidan and Schilling, 495 2004; Walker and Kimmel, 2007) . Animals were imaged using a Nikon SMZ18 fluorescent 496 stereomicroscope with an image capture system, and craniofacial measurements were obtained in 497
ImageJ. Ordinary one-way ANOVA used for statistical analyses. Fluorescent images were acquired 498 using a Nikon A1 laser scanning confocal system with a CF175 Apochromat LWD 25x water-499 immersion objective. Primary antibodies are as follows with dilutions: Anti-acetylated α-tubulin 500 (Sigma, 1:1000), anti-γ-tubulin (Sigma, 1:100), znp-1 (anti-synaptotagmin2; DHSB, 1:25), zpr1 501 (ZIRC, 1:100), zpr3 (ZIRC, 1:100), anti-col2a1a (DHSB, 1:100), anti-GFP (Abcam, 1:1000). Alexa 502 fluor conjugated secondary antibodies, DAPI (LifeTech), and toto-3 (Life Technologies) were used 503 after primary antibody incubation. 504
Injection of Endocytic Tracers and Analysis 505
Lysine-fixable 10 kDa dextran (Alexa 488 conjugated) or 500 kDa dextran (FITC conjugated) 506 (Thermo Fisher) were prepared in PBS at 2 µg/µl final concentration. In addition, recombinant Cy3-507 conjugated His-tagged RAP (39 kDa), prepared in PBS at 5 µg/µl final concentration, was kindly 508 provided by Dr. Martin Lowe (University of Manchester). Zebrafish embryos were anesthetized in 509 tricaine (0.013% w/v; Fisher Scientific) diluted in embryo water at 72 hpf. Approximately 0.5-1 nl 510 of dextran or RAP was injected into the common cardinal vein using a glass micropipette and a 511 pneumatic pressure injector (PLI90; Harvard Apparatus) and micromanipulator. Uptake in the 512 renal tubular cells of the proximal pronephros was analyzed 1-2.5 hours post-injection (hpi), using 513 a Nikon SMZ18 fluorescent stereomicroscope with an image capture system. Animals injected with 514 500 kDa Dextran were analyzed 24 hpi. Statistical analyses performed using Pearson's chi-squared 515 test. 516
Morpholino Inhibition of OCRL Gene Expression 517
Morpholino (MO) knockdown of ocrl1 was performed as previously described (Coon et al., 2012) , 518 and was kindly provided by Dr. Martin Lowe (University of Manchester). A translation blocking MO 519 was utilized and 1-5 ng/ul was injected into embryos at the 1-cell stage (sequence: 520 AATCCCAAATGAAGGTTCCATCATG). The specificity of this MO has previously been validated by 521 rescue ocrl1 mRNA experiments (Coon et al., 2012) . 522
Cilia and Craniofacial Quantification/Analysis 523
Cilia in the anterior portion (just anterior to the yolk extension) and posterior portion (near the 524 cloacae) of the pronephros in the zebrafish larvae were selected and analyzed. The number of cilia 525 within a 100x100 micron area were quantified, and the length of five randomly selected cilia were 526 measured within the area. Craniofacial morphometric measurements were obtained with Fiji 527 (Schindelin et al., 2012) . Type II collagen was quantified by mean fluorescence intensity within a 528 2500 µm 2 area in the ceratohyal cartilage and a 1000 µm 2 area in Meckel's cartilage. 529
BMV109 Delivery and in-gel analyses 530
The BMV109 fluorescent ABP was injected into 3 dpf larvae (1 nl at 10 µM) pericardially via 531 microinjection. This equates to a final global concentration of 10 nM. Probe was circulated over 532 night at 28.8°C and harvested at 15 hpi. 25 larvae per condition were collected and lysed in citrate 533 buffer (50 mM citrate buffer pH5.5, 5 mM DTT, 0.5% CHAPS, 0.75% Triton X-100) by brief 534 sonication. Samples were centrifuged for 15 minutes at 15,000g and the supernatant collected. 535
Protein concentration was determined via a micro BCA assay (cat#23235; Thermo Fisher) and 536 samples run on 4-20% precast gradient gels containing the "stain free" tri-halo compound (Bio-537 Rad). UV light activated tri-halo covalently binds tryptophan residues. Equivalent protein loads 538 were evaluated on a Bio-Rad Chemidoc MP Imaging System using this stain-free method. BMV109 539
Cy5 fluorescence was subsequently analyzed in gel. Total protein load per lane and individual ABP-540 reactive bands were quantitated using Chemidoc MP software. Individual ABP-reactive bands were 541 normalized to total protein load and the fold difference calculated between WT and MLII samples. 542
Gel images were processed on Adobe Photoshop (CS6 extended, version 13.0). 543
Pharmacological inhibition 544
Cathepsin K activity was inhibited from 3 to 4 dpf in live embryos by introducing the 50 nM 545 odanacatib (solubilized in DMSO) directly into their growth media. In all cases, WT control larvae 546 were treated with an equivalent amount of DMSO (0.1%). 547
Cell Culture 548
HeLa cells (ATCC CCL-2) were grown in DMEM supplemented with 5% FBS (Thermo Fisher) and 549 1% penicillin-streptomycin (Life Technologies). Cells were transfected using Effectene (Qiagen) 550 according to instructions provided by the manufacturer. The FAM109A cDNA was synthesized by 551
Genewiz and cloned into the pEGFP-C3 vector (Promega). The R6C mutation was introduced into 552 the construct using the Q5 site-directed mutagenesis kit (NEB). The pcDNA3-HA-human OCRL 553 plasmid was a gift from Pietro De Camilli (Addgene plasmid # 22207 ; 554 http://n2t.net/addgene:22207 ; RRID:Addgene_22207). 555
Protein-protein Interaction: 556
Lysates were prepared from transfected HeLa cells by incubating the cell pellet in RIPA buffer (50 557 mM Tris-Cl pH 7.5, 150 nM NaCl, 1% NP40, 1 mM EDTA). The lysate was clarified by centrifugation 558 at 10,000g for 5 minutes at 40C. 1x Halt protease inhibitor cocktail (Pierce) was added to the lysate. 559 800 µg total protein was used per immunoprecipitation. Immunoprecipitation was done using GFP-560
Trap beads (Chromotek) in binding buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.2 mM EDTA, 0.05% 561 NP40). The lysate was incubated with beads for 75 min at Supplementary Figure S1 
